(Q67925782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Effectiveness of Oral Diclofenac in the Acute Treatment of Common Migraine Attacks: A Double-Blind Study Versus Placebo (English)

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

11 December 2022

1 reference

1 reference

1 reference

H. Massiou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860132

11 December 2022

D. Serrurier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860132

11 December 2022

O. Lasserre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860132

11 December 2022

M. G. Bousser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860132

11 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1860132

11 December 2022

publication date

1 May 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.1991.1102059.x

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

11 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

59-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

Tolfenamic acid is as effective as ergotamine during migraine attacks

19 September 2019

cites work

4

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Naproxen sodium in the treatment of migraine

11 December 2022

5

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks

11 December 2022

6

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Treatment of Acute Migraine Attack: Naproxen and Placebo Compared

11 December 2022

7

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine

11 December 2022

9

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

11 December 2022

10

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks

11 December 2022

11

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial

11 December 2022

12

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Treatment review: non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks

11 December 2022

13

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Methodological aspects of drug trials in migraine.

11 December 2022

14

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

The two-period cross-over clinical trial

11 December 2022

15

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

Drug trials in migraine. The clinician's view on end points

11 December 2022

16

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.1991.1102059.X

11 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1860132%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference